Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

[ad_1]

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.

[ad_2]

Source link